CLDX – Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.CLDX
$23.78Name : Celldex Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $1,577,665,152.00
EPSttm : -2.58
Celldex Therapeutics, Inc.
$23.78
4.48%$1.02Float Short %
12.5
Margin Of Safety %
Put/Call OI Ratio
0.54
EPS Next Q Diff
-0.21
EPS Last/This Y
0.52
EPS This/Next Y
-0.93
Price
23.79
Target Price
67.1
Analyst Recom
1.33
Performance Q
-19.99
Relative Volume
0.8
Beta
1.61
Ticker: CLDX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | CLDX | 25.4 | 0.52 | 4.50 | 18551 |
| 2024-12-20 | CLDX | 25.15 | 0.52 | 0.11 | 18543 |
| 2024-12-23 | CLDX | 24.79 | 0.52 | 1.30 | 18060 |
| 2024-12-24 | CLDX | 25.13 | 0.53 | 0.01 | 18195 |
| 2024-12-26 | CLDX | 25.62 | 0.51 | 0.05 | 18703 |
| 2024-12-27 | CLDX | 25.38 | 0.49 | 0.53 | 19234 |
| 2024-12-30 | CLDX | 25.15 | 0.49 | 0.00 | 19246 |
| 2024-12-31 | CLDX | 25.26 | 0.49 | 0.32 | 19245 |
| 2025-01-02 | CLDX | 25.94 | 0.49 | 0.12 | 19343 |
| 2025-01-03 | CLDX | 26.82 | 0.49 | 0.93 | 19383 |
| 2025-01-06 | CLDX | 26.56 | 0.52 | 1.84 | 21543 |
| 2025-01-07 | CLDX | 27.76 | 0.49 | 4.47 | 21305 |
| 2025-01-08 | CLDX | 26.54 | 0.54 | 4.63 | 22924 |
| 2025-01-09 | CLDX | 26.53 | 0.54 | 4.63 | 22924 |
| 2025-01-10 | CLDX | 24.34 | 0.54 | 5.10 | 22881 |
| 2025-01-13 | CLDX | 24.3 | 0.56 | 0.11 | 23526 |
| 2025-01-14 | CLDX | 22.91 | 0.55 | 0.03 | 23726 |
| 2025-01-15 | CLDX | 22.61 | 0.54 | 6.15 | 23707 |
| 2025-01-16 | CLDX | 22.71 | 0.55 | 3.30 | 23737 |
| 2025-01-17 | CLDX | 23.8 | 0.54 | 0.44 | 23825 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | CLDX | 25.37 | -22.7 | -81.1 | -2.40 |
| 2024-12-20 | CLDX | 25.16 | -22.7 | -67.2 | -2.40 |
| 2024-12-23 | CLDX | 24.77 | -22.7 | -64.4 | -2.40 |
| 2024-12-24 | CLDX | 25.13 | -22.7 | -77.7 | -2.40 |
| 2024-12-26 | CLDX | 25.65 | -22.7 | -80.5 | -2.40 |
| 2024-12-27 | CLDX | 25.40 | -22.7 | -66.7 | -2.40 |
| 2024-12-30 | CLDX | 25.09 | -22.7 | -65.9 | -2.40 |
| 2024-12-31 | CLDX | 25.26 | -22.7 | -73.6 | -2.40 |
| 2025-01-02 | CLDX | 25.81 | -22.7 | -80.6 | -2.40 |
| 2025-01-03 | CLDX | 26.85 | -22.7 | -89.2 | -2.40 |
| 2025-01-06 | CLDX | 26.59 | -22.7 | -67.6 | -2.40 |
| 2025-01-07 | CLDX | 27.57 | -22.7 | -87.1 | -2.40 |
| 2025-01-08 | CLDX | 26.53 | -22.7 | -55.1 | -2.40 |
| 2025-01-09 | CLDX | 26.53 | -22.7 | -71.2 | -2.40 |
| 2025-01-10 | CLDX | 24.35 | -22.7 | -36.0 | -2.40 |
| 2025-01-13 | CLDX | 24.30 | -22.7 | -70.2 | -2.40 |
| 2025-01-14 | CLDX | 22.92 | -22.7 | -44.7 | -2.40 |
| 2025-01-15 | CLDX | 22.64 | -22.7 | -64.7 | -2.40 |
| 2025-01-16 | CLDX | 22.75 | -22.7 | -73.9 | -2.40 |
| 2025-01-17 | CLDX | 23.79 | -22.7 | -93.1 | -2.40 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | CLDX | 0.70 | 3.63 | 11.90 |
| 2024-12-20 | CLDX | 0.70 | 3.63 | 11.90 |
| 2024-12-23 | CLDX | 0.71 | 3.63 | 11.90 |
| 2024-12-24 | CLDX | 0.71 | 3.63 | 11.90 |
| 2024-12-26 | CLDX | 0.69 | 3.63 | 11.30 |
| 2024-12-27 | CLDX | 0.69 | 3.63 | 11.30 |
| 2024-12-30 | CLDX | 0.71 | 3.60 | 11.30 |
| 2024-12-31 | CLDX | 0.71 | 3.60 | 11.30 |
| 2025-01-02 | CLDX | 0.70 | 3.60 | 11.30 |
| 2025-01-03 | CLDX | 0.70 | 3.60 | 11.30 |
| 2025-01-06 | CLDX | 0.68 | 3.60 | 11.30 |
| 2025-01-07 | CLDX | 0.68 | 3.60 | 11.30 |
| 2025-01-08 | CLDX | 0.70 | 3.60 | 11.30 |
| 2025-01-09 | CLDX | 0.70 | 3.60 | 11.30 |
| 2025-01-10 | CLDX | 0.70 | 3.60 | 11.30 |
| 2025-01-13 | CLDX | 0.70 | 3.66 | 12.50 |
| 2025-01-14 | CLDX | 0.70 | 3.66 | 12.50 |
| 2025-01-15 | CLDX | 0.70 | 3.66 | 12.50 |
| 2025-01-16 | CLDX | 0.70 | 3.66 | 12.50 |
| 2025-01-17 | CLDX | 0.70 | 3.66 | 12.50 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.64
Avg. EPS Est. Current Quarter
-0.73
Avg. EPS Est. Next Quarter
-0.85
Insider Transactions
0.7
Institutional Transactions
3.66
Beta
1.61
Average Sales Estimate Current Quarter
1
Average Sales Estimate Next Quarter
Fair Value
Quality Score
25
Growth Score
38
Sentiment Score
2
Actual DrawDown %
58.4
Max Drawdown 5-Year %
-63.6
Target Price
67.1
P/E
Forward P/E
PEG
P/S
158.08
P/B
2.01
P/Free Cash Flow
EPS
-2.57
Average EPS Est. Cur. Y
-2.4
EPS Next Y. (Est.)
-3.33
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-1544.48
Relative Volume
0.8
Return on Equity vs Sector %
-38.7
Return on Equity vs Industry %
-26.1
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
-93.1
Celldex Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 160
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.
stock quote shares CLDX – Celldex Therapeutics, Inc. Stock Price stock today
news today CLDX – Celldex Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLDX – Celldex Therapeutics, Inc. yahoo finance google finance
stock history CLDX – Celldex Therapeutics, Inc. invest stock market
stock prices CLDX premarket after hours
ticker CLDX fair value insiders trading